Daniel R. Chevallard - Insider Trading & Ownership

Location: C/O Regulus Therapeutics Inc., 10614 Science Center Drive, San Diego, CA
Summary: The estimated net worth of Daniel R. Chevallard is at least $214K dollars as of November 7, 2025. Daniel R. Chevallard is the Chief Financial Officer of LENZ Therapeutics, Inc. and owns shares of LENZ Therapeutics, Inc. (LENZ) stock worth about $123K. Daniel R. Chevallard is the CFO and COO of Viracta Therapeutics, Inc. and owns shares of Viracta Therapeutics, Inc. (VIRX) stock worth about $91.9K.
Signature: /s/ Daniel R. Chevallard
All Insider Reports: All Insider Reports

Notify me when Daniel R. Chevallard files a new Insider Trading report.

Ownership of Daniel R. Chevallard

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
LENZ	LENZ Therapeutics, Inc.	Chief Financial Officer	$123K	+$50K	+68.9%	Nov 7, 2025
VIRX	Viracta Therapeutics, Inc.	CFO and COO	$91.9K			Mar 12, 2024

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.